ASAP1 and breast cancer: We first found that a highly invasive model cell line of ccRCCs, namely 786-O, expressed Arf6, AMAP1 and EPB41L5 at high levels, almost comparative with those observed in highly invasive breast cancer model cell line MDA-MB-231 (ref. 17; Fig. 1a).